Kura Oncology Inc (KURA) Live Share Price, Invest From India

Kura Oncology Inc Stock Performance

as on December 20, 2025 at 2:29 am IST

Day's Low
Day's High
$9.83
Day's Price Range
$10.15
$9.85
0.20%
Downside
3.05%
Upside
52 Week's Low
52 Week's High
$5.41
52-Week Price Range
$12.49
$9.85
45.08%
Downside
26.80%
Upside

Kura Oncology Inc share price movements today

Previous Close: $9.85
Open: $9.95
Volume: 949.4K
Day's Low - High: $9.83 - $10.15
52 Week Low - High: $5.41 - $12.49

Kura Oncology Inc Historical Returns

1 Month Return: -10.38 %
3 Month Return: + 19.27 %
1 Year Return: + 9.21 %
3 Year Return: -17.93 %
5 Year Return: -73.5 %

Kura Oncology Inc Stock Fundamentals & Key Indicators

Check Kura Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$857.1M

EPS (TTM)

-2.3389

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-239.0M

Revenue (TTM)

104.0M

Profit Margin

-208.48%

Return On Equity TTM

-65.10%

Kura Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kura Oncology Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Kura Oncology Inc	BUY	$857.1M	-73.5%	NA	-208.48%
Insmed Incorporated	BUY	$37.3B	371.01%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$52.3B	181.08%	1237.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$114.7B	92.72%	31.44	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$79.4B	53.93%	17.95	32.13%

Stock Returns calculator for Kura Oncology Inc Stock including INR - Dollar returns

The Kura Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Kura Oncology Inc investment value today

Current value as on today

₹1,14,554

Returns

₹14,554

(+14.55%)

Returns from Kura Oncology Inc Stock

₹9,323 (+9.32%)

Dollar Returns*

₹5,231 (+5.23%)

Analyst Recommendation on Kura Oncology Inc Stock

Based on 20 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Kura Oncology Inc. Average target price of $33

Kura Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Kura Oncology Inc.

What analysts predicted

70.15%UPSIDE

Target Price

$33

Current Price

$9.85

Analyzed by

20 Analysts

Target

$33.00

Kura Oncology Inc target price $33, a slight upside of 70.15% compared to current price of $9.85. According to 20 analysts rating.

Kura Oncology Inc Stock’s Investor Sentiment and Interest

Search interest for Kura Oncology Inc Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Time period: November 21, 2025 to December 21, 2025

Change:4% versus previous 30 day period

Kura Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	1	-	-	-	53	14	15	20
Gross Profit	0	0	0	0	0	0	53	14	15	17
Operating Income	-40	-42	-46	-54	-56	-59	-22	-64	-72	-79
EBITDA	-36	-37	-42	-48	-50	-53	-16	-64	-65	-73
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-37	-38	-42	-49	-50	-54	-17	-57	-66	-74
Income Tax Expense	0	0	2	0	-	-	2	0	-	-
Net Income	-37	-38	-42	-49	-50	-54	-19	-57	-66	-74
Net Profit Margin	0.00%	0.00%	-3368.98%	0.00%	0.00%	0.00%	-35.66%	-407.07%	-432.51%	-357.19%

Kura Oncology Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	53
Gross Profit	0	0	0	0	-	0	0	0	0	53
Operating Income	-23	-28	-36	-62	-67	-91	-131	-139	-165	-193
EBITDA	-23	-28	-36	-62	-67	-88	-129	-134	-150	-169
Interest Expense	0	0	0	0	0	0	0	0	1	1
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-22	-27	-35	-60	-63	-89	-130	-135	-152	-171
Income Tax Expense	0	0	0	3	-4	0	0	0	-	2
Net Income	-22	-27	-35	-60	-63	-89	-130	-135	-152	-173
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-322.89%

Kura Oncology Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-38	-42	-49	-50	-54	-19	-57	-66	-74
Operating Cash Flow	-29	-34	-48	-42	-43	269	-71	-28	-80
Investing Cash Flow	8	42	-95	43	45	-94	-101	58	93
Financing Cash Flow	0	0	148	3	2	0	0	0	-
Change in Cash	-20	8	4	3	4	174	-173	30	13

Kura Oncology Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-27	-35	-60	-63	-89	-130	-135	-152	-173
Operating Cash Flow	-25	-28	-48	-54	-69	-104	-110	-124	134
Investing Cash Flow	12	-23	-79	-46	-99	-126	32	15	-101
Financing Cash Flow	7	53	132	111	469	-3	38	94	154
Change in Cash	-5	1	4	10	299	-234	-38	-14	187

Global Institutional Holdings in Kura Oncology Inc

Funds	Holdings
BlackRock Inc	10.91%
Suvretta Capital Management, LLC	9.35%
Bvf Inc	8.93%
Armistice Capital, LLC	7.14%
Vanguard Group Inc	6.16%

See all

Insights on Kura Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, KURA stock has moved up by 68.2%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 779.0% return, outperforming this stock by 797.1%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 148.2% return, outperforming this stock by 139.0%

About Kura Oncology Inc

at kura oncology, we are committed to realizing the promise of precision medicines for cancer. the genomics revolution is transforming how we treat cancer. we now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. this new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. we are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. our development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias. our goal is to help patients with cancer lead better, longer lives.

Organisation	Kura Oncology Inc
Headquarters	12730 High Bluff Drive, San Diego, CA, United States, 92130
Industry	Health Technology
CEO	Dr. Troy Edward Wilson J.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Kura Oncology Inc

Name	Title
Mr. Thomas Doyle	Senior Vice President of Finance & Accounting
Dr. Roger Bakale Ph.D.	Senior Vice President of Manufacturing & Supply Chain
Dr. Mollie Leoni M.D.	Chief Medical Officer
Dr. Troy Edward Wilson J.D., Ph.D.	Chairman, CEO & President
Ms. Teresa Brophy Bair Esq., J.D.	Chief Legal Officer & Corporate Secretary
Mr. Greg Mann	Senior Vice President of Investor Relations & Corporate Affairs
Ms. Maureen Clancy M.B.A.	VP and Global Head of Program Leadership & Project Management
Mr. Brian T. Powl M.B.A., M.S.	Chief Commercial Officer
Ms. Kathleen Ford	Chief Operating Officer
Dr. Francis J. Burrows Ph.D.	Chief Scientific Officer

FAQs

What is Kura Oncology Inc share price today?

Kura Oncology Inc share price today is $9.85 as on December 20, 2025 at 2:29 am IST at the close of the market. Kura Oncology Inc share today touched a day high of $10.15 and a low of $9.83.

What is the 52 week high and 52 week low for Kura Oncology Inc share?

Kura Oncology Inc share touched a 52 week high of $12.49 on November 14, 2025 and a 52 week low of $5.41 on April 7, 2025. Kura Oncology Inc stock price today i.e. December 20, 2025 at 2:29 am IST is closed at $9.85,which is 21.14% down from its 52 week high and 82.07% up from its 52 week low.

What is Kura Oncology Inc's market capitalisation today?

Kura Oncology Inc market capitalisation is $0.00T as on December 20, 2025 at 2:29 am IST.

How to invest in Kura Oncology Inc Stock (KURA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kura Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kura Oncology Inc Shares that will get you 0.1523 shares as per Kura Oncology Inc share price of $9.85 per share as on December 20, 2025 at 2:29 am IST.

What is the minimum amount required to buy Kura Oncology Inc Stock (KURA) from India?

Indian investors can start investing in Kura Oncology Inc (KURA) shares with as little as ₹89.552 or $1 (as of December 21, 2025 at 7:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Kura Oncology Inc stock (as per the Rupee-Dollar exchange rate as on December 21, 2025 at 7:38 pm IST). Based on Kura Oncology Inc share’s latest price of $9.85 as on December 20, 2025 at 2:29 am IST, you will get 1.0152 shares of Kura Oncology Inc. Learn more about fractional shares .

What are the returns that Kura Oncology Inc has given to Indian investors in the last 5 years?

Kura Oncology Inc stock has given -73.5% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?